Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial of ICM with or without AZD2281 (olaparib) in patients with advanced pancreatic cancer; the study is completed and results were…
-
CLINICAL_TRIALS safety_alert · 2016-03-14Clinical Trial Update: Incretin-based Drugs and Pancreatic Cancer
A completed observational study assessing whether incretin-based therapies for type 2 diabetes are linked to pancreatic cancer, highlighting…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer [EARLY_Phase 1]
An update on an early-phase Phase 1 trial evaluating pre-operative Cyberknife radiotherapy for potentially resectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma [Phase 1]
A Phase 1 clinical trial evaluating mesothelin-directed autologous T cells for advanced pancreatic cancer. The document provides sponsor and…
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Identification of Biomarkers for Early Detection of Pancreatic Cancer
A completed clinical trial reporting on the identification of biomarkers for early detection of pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct
A clinical trial comparing single Roux-en-Y versus traditional Roux-en-Y pancreaticojejunostomy-choledochojejunostomy for obstruction of the…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer [Phase 1]
Phase I study of gemcitabine, sorafenib and radiotherapy in patients with unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients [Phase 3]
Phase 3 trial evaluating megestrol acetate concentrated suspension for cancer-related anorexia in patients with lung or pancreatic cancer; t…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation
This completed prospective study evaluates the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration and biopsy for pan…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer [NA]
An update on a first-line trial evaluating decitabine in combination with gemcitabine for advanced pancreatic cancer; no trial outcomes are …
-
FDA approval · 2016-02-17FDA Approved: FLUOROURACIL — Original Application (Sagent Pharmaceuticals)
FDA approves an Original Application for Fluorouracil from Sagent Pharmaceuticals, establishing a generic injectable form of the chemotherap…
-
CLINICAL_TRIALS research · 2016-02-15Clinical Trial Update: Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
Clinical trial update on evaluating pancreatic steatosis in patients with pancreatic cancer; no results or outcomes are reported in this ent…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer [Phase 3]
This clinical trial update summarizes the Phase 3 results of MM-398 (liposomal irinotecan) with or without 5-FU/leucovorin versus 5-FU/leuco…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body [Phase 1]
Phase 1 study of galunisertib (LY2157299) in pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2016-02-05Clinical Trial Update: A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment [Phase 2]
Phase 2 clinical trial evaluating Tl-118 in combination with Gemcitabine for metastatic pancreatic cancer; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 trial evaluating a combination of gemcitabine, infusional 5-fluorouracil, and…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess [Phase 3]
Phase 3 placebo-controlled trial of SOM230 (pasireotide) to reduce post-pancreatectomy fistula, leak, and abscess in pancreatic cancer patie…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions [NA]
Completed clinical trial evaluating parenteral nutrition in patients with biliopancreatic mass lesions. The study included individuals with …
-
CLINICAL_TRIALS withdrawal · 2016-01-28Clinical Trial Update: Clinical Outcomes in Hereditary Cancer
A clinical trial evaluating clinical outcomes in hereditary cancer sponsored by Memorial Sloan Kettering Cancer Center has been withdrawn, w…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Autologous Natural Killer T Cells Infusion for the Treatment of Cancer [NA]
Clinical trial update on autologous natural killer T cell infusion for cancer with unknown status at this time.
-
FDA approval · 2016-01-26FDA Approved: GEMCITABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' supplemental application for gemcitabine hydrochloride (gemcitabine), enabling continued producti…
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy
Clinical trial study update examining changes in IgG4 and IL-10 in pancreatic cancer patients after chemotherapy.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]
Phase 1 clinical trial evaluating a HER2-positive T cell–mediated adaptive therapy for digestive-system cancers, including esophageal, gastr…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer [Phase 1]
This is a Phase 1 clinical trial update on a vaccine therapy for pancreatic cancer patients with resected or locally advanced unresectable d…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating radiation therapy for extrahepatic bile duct cancer, gallbladder cancer, and pancreatic cancer has completed.